Clinical trial
Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
NCT00232375 · Tokyo Study Group, Other · Completed
Key facts
| NCT number | NCT00232375 |
|---|---|
| Title | Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes |
| Lead sponsor | Tokyo Study Group, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | GAD Ab Positive Clinically Type 2 Diabetic Patients |
| Intervention type | Drug |
| Interventions | Insulin |
| Enrollment | 42 |
| Start date | Jan 1, 1996 |
| Completion | Jan 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Oct 4, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: